Thermo Fisher Scientific (TMO), the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”